American Cancer Society. (2014, July 2). Cancer - Unknown Primary. Atlanta, GA. Retrieved on 08/25/2014. Retrieved from: http://www.cancer.org/acs/groups/cid/documents/webcontent/003092-pdf.pdf.
Fizazi K, Greco FA, Pavlidis N, et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2011). Annals of Oncology. Oxford University Press. 22(Supplement 5): vi64-vi68 doi: 10.1093/annoc/mdr389.
Greco FA. Cancer of unknown primary site: improved patient management with molecular and immunohistochemical diagnosis. 2013 ASCO Educational Book. Alexandria, VA: American Society of Clinical Oncology.
Greco FA & Hainsworth JD. Cancer of unknown primary site. DeVita VT Jr, Lawrence TS, & Rosenberg SA. (2015). Cancer: Principles & Practice of Oncology. (10th Edition). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. 113:1720-1737.
Hainsworth JD, Greco FA. Chemotherapy of carcinoma of unknown primary site. Perry MC, Doll DC, Freter CE. (2012). Perry's The Chemotherapy Source Book. (5th Edition). Lippincott Williams Wilkins. Chapter 37. Retrieved from: http://www.lwwoncology.com.
Lisovsky M, Tafe LJ, Lefferts JA. Molecular diagnostics of metastatic malignancies. Tan D, Lynch, HT (eds.). (2013). Principles of Molecular Diagnostics and Personalized Cancer Medicine. Lippincott Williams & Wilkins. Chapter 42.
National Cancer Institute. (2015, July 8). Carcinoma of Unknown Primary Treatment (PDQ®) Health Professional Version.
National Comprehensive Cancer Network. Occult Primary (Cancer of Unknown Primary [CUP]) (Version 3.2014). Retrieved on 7/7/2014. Retrieved from: http://www.nccn.org/professionals/physician_gls/pdf/occult.pdf.×